4531 logo

Yuki Gosei Kogyo Co., Ltd. Stock Price

TSE:4531 Community·JP¥7.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4531 Share Price Performance

JP¥0
-269.00 (-100.00%)
JP¥0
-269.00 (-100.00%)
Price JP¥0

4531 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

Yuki Gosei Kogyo Co., Ltd. Key Details

JP¥15.7b

Revenue

JP¥13.2b

Cost of Revenue

JP¥2.6b

Gross Profit

JP¥2.1b

Other Expenses

JP¥417.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
19.36
16.27%
2.65%
48.7%
View Full Analysis

About 4531

Founded
1947
Employees
296
CEO
Seiichiro Matsumoto
WebsiteView website
www.yuki-gosei.co.jp

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets amino acids, chemical products, and pharmaceuticals in Japan and internationally. It offers food additives, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, active pharmaceutical ingredients, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was incorporated in 1947 and is headquartered in Chuo, Japan.

Recent 4531 News & Updates

Recent updates

No updates